JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doherty, T. M.
Right arrow Articles by Andersen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doherty, T. M.
Right arrow Articles by Andersen, P.
Journal of Clinical Microbiology, February 2002, p. 704-706, Vol. 40, No. 2
0095-1137/01/$04.00+0     DOI: 10.1128/JCM.40.2.704-706.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Immune Responses to the Mycobacterium tuberculosis-Specific Antigen ESAT-6 Signal Subclinical Infection among Contacts of Tuberculosis Patients

T. Mark Doherty,1* Abebech Demissie,2 Joseph Olobo,2 Dawit Wolday,3 Sven Britton,4 Tewodros Eguale,5 Pernille Ravn,6 and Peter Andersen1

Department of Tuberculosis Immunology, Statens Serum Institute,1 Hvidovre Hospital, Copenhagen, Denmark,6 Armauer Hansen Research Institute,2 Black Lion Hospital,3 Hossana Regional Hospital, Ministry of Health, Hossanna, Ethiopia,5 Karolinska Institute, Stockholm, Sweden4

Received 25 April 2001/ Returned for modification 29 July 2001/ Accepted 4 November 2001

Diagnosis of latent Mycobacterium tuberculosis infection is considered essential for tuberculosis control but is hampered by the lack of specific reagents. We report that strong recognition of tuberculosis complex-specific antigen ESAT-6 by healthy household contacts of tuberculosis patients correlates with the subsequent development of active tuberculosis during a 2-year follow-up period.


* Corresponding author. Mailing address: Department of Tuberculosis Immunology, Statens Serum Institute, Artillerivej 5, 2300 Copenhagen S, Denmark. Phone: 45 32 68 38 44. Fax: 45 32 68 30 35. E-mail: TMD{at}ssi.dk.


Journal of Clinical Microbiology, February 2002, p. 704-706, Vol. 40, No. 2
0095-1137/01/$04.00+0     DOI: 10.1128/JCM.40.2.704-706.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.